Seraxis is a privately held biotechnology company with operations located in the BioHealth Capital Region, Maryland. Seraxis proprietary transplant ready islets and device were developed in house. Seraxis is advancing its cell therapy/device combination, SR-01 to the clinic.
Market
Cell therapy and medical devices
Location
Germantown,
Maryland,
USA
Coinvestors
Eli Lilly and Company, Frazier Healthcare Partners, JDRF T1D Fund, Polaris Ventures